We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$16.6B
AUM Growth
+$973M
Cap. Flow
-$466M
Cap. Flow %
-2.8%
Top 10 Hldgs %
30.85%
Holding
337
New
11
Increased
98
Reduced
190
Closed
11

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$43.9M
2
DELL icon
Dell
DELL
+$36.8M
3
CME icon
CME Group
CME
+$29.7M
4
AFG icon
American Financial Group
AFG
+$18.4M
5
WMB icon
Williams Companies
WMB
+$16.6M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$49.2M
2
AVGO icon
Broadcom
AVGO
+$43.2M
3
UPS icon
United Parcel Service
UPS
+$26.7M
4
PLD icon
Prologis
PLD
+$26.4M
5
ABT icon
Abbott
ABT
+$26M

Sector Composition

Rank Sector Weight
1 Technology 22.48%
2 Healthcare 14.22%
3 Financials 13.06%
4 Industrials 12.03%
5 Consumer Staples 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
76
Union Pacific
UNP
$174B
$37.5M 0.23%
152,732
-6,048
-4% -$1.33M
RPM icon
77
RPM International
RPM
$15B
$36.2M 0.22%
323,943
+2,098
+0.7% +$212K
IPAR icon
78
Interparfums
IPAR
$3.94B
$34.3M 0.21%
238,175
-17,849
-7% -$2.33M
OTIS icon
79
Otis Worldwide
OTIS
$28.2B
$34.2M 0.21%
382,036
-4,426
-1% -$368K
DOX icon
80
Amdocs
DOX
$6.22B
$33.2M 0.2%
377,316
+9,436
+3% +$786K
ECL icon
81
Ecolab
ECL
$79.9B
$29.4M 0.18%
148,322
-11
-0% -$1.98K
DGX icon
82
Quest Diagnostics
DGX
$26.3B
$29.4M 0.18%
212,951
+29,469
+16% +$3.87M
CME icon
83
CME Group
CME
$94.8B
$29.3M 0.18%
+139,030
New +$29.7M
VCTR icon
84
Victory Capital Holdings
VCTR
$6.65B
$28.3M 0.17%
822,668
+38,895
+5% +$1.24M
ATO icon
85
Atmos Energy
ATO
$28.8B
$27.4M 0.16%
236,259
+2,437
+1% +$272K
BX icon
86
Blackstone
BX
$110B
$27.3M 0.16%
208,399
+361
+0.2% +$39.1K
TRGP icon
87
Targa Resources
TRGP
$55.1B
$27.2M 0.16%
312,937
+161,097
+106% +$13.8M
CSGS
88
DELISTED
CSG Systems International
CSGS
$27.1M 0.16%
508,748
+24,385
+5% +$1.25M
PRGO icon
89
Perrigo
PRGO
$1.78B
$27M 0.16%
839,558
+11,913
+1% +$356K
NSP icon
90
Insperity
NSP
$2.01B
$26.6M 0.16%
227,339
+6,021
+3% +$651K
HPQ icon
91
HP
HPQ
$27.5B
$26.5M 0.16%
881,188
-18,692
-2% -$524K
BDX icon
92
Becton Dickinson
BDX
$48.2B
$26.1M 0.16%
107,146
-931
-0.9% -$229K
LHX icon
93
L3Harris
LHX
$53.4B
$25.6M 0.15%
121,361
-22,169
-15% -$4.16M
MDC
94
DELISTED
M.D.C. Holdings, Inc.
MDC
$23.8M 0.14%
430,168
+8,065
+2% +$357K
JCI icon
95
Johnson Controls International
JCI
$92.2B
$23.6M 0.14%
408,741
-51,925
-11% -$2.73M
NTAP icon
96
NetApp
NTAP
$37.2B
$22.3M 0.13%
252,863
+5,405
+2% +$435K
HOMB icon
97
Home BancShares
HOMB
$6.18B
$22.2M 0.13%
875,757
+16,835
+2% +$375K
NI icon
98
NiSource
NI
$20.4B
$21.9M 0.13%
824,955
+48,779
+6% +$1.25M
ADC icon
99
Agree Realty
ADC
$9.41B
$21.8M 0.13%
345,863
-3,682
-1% -$213K
AVY icon
100
Avery Dennison
AVY
$13.4B
$21.6M 0.13%
106,805
+1,707
+2% +$319K

Similar funds

Bahl & Gaynor's Q4 2023 Portfolio in Review

As of Q4 2023, Bahl & Gaynor held 337 positions worth $16.6B, up 6.2% from $15.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2023 filing shows 11 new, 98 increased, 190 reduced and 11 closed positions. Its largest new stake was Dell: 520,900 shares worth $39.8M. The largest sale was Medtronic, an estimated $49.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2023 buy was Dell: 520,900 shares worth $39.8M.
  • Bahl & Gaynor added most to Amgen in Q4 2023, an estimated $43.9M increase.
  • Bahl & Gaynor's biggest Q4 2023 reduction was Medtronic, cutting an estimated $49.2M.
  • Bahl & Gaynor fully exited SBA Communications in Q4 2023, selling an estimated $375K.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $16.6B portfolio in Q4 2023.
  • Bahl & Gaynor opened 11 new positions and closed 11 in Q4 2023.
  • Bahl & Gaynor's portfolio value rose 6.2% quarter-over-quarter to $16.6B.

Based on Bahl & Gaynor's 13F filing for Q4 2023, filed 2 Feb 2024.